Search Results - "Laville, Isabelle"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Photodynamic Efficiency of Diethylene Glycol-Linked Glycoconjugated Porphyrins in Human Retinoblastoma Cells by Laville, Isabelle, Pigaglio, Sophie, Blais, Jean-Claude, Doz, François, Loock, Bernard, Maillard, Philippe, Grierson, David S., Blais, Jocelyne

    Published in Journal of medicinal chemistry (20-04-2006)
    “…Photodynamic therapy (PDT) is emerging as a new strategy for the conservative treatment of hereditary retinoblastoma. The glycoconjugated porphyrins…”
    Get full text
    Journal Article
  2. 2

    Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival by Poiseuil, Marie, Molinié, Florence, Dabakuyo-Yonli, Tienhan Sandrine, Laville, Isabelle, Fauvernier, Mathieu, Remontet, Laurent, Amadeo, Brice, Coureau, Gaëlle

    Published in International journal of cancer (07-09-2024)
    “…In most developed countries, both organized screening (OrgS) and opportunistic screening (OppS) coexist. The literature has extensively covered the impact of…”
    Get full text
    Journal Article
  3. 3

    Microbiological and Physicochemical Stability of Fentanyl and Sufentanil Solutions for Patient-Controlled Delivery Systems by Chapalain-Pargade, Sophie, Laville, Isabelle, Paci, Angelo, Chachaty, Elisabeth, Mercier, Lionel, Bourget, Philippe

    Published in Journal of pain and symptom management (01-07-2006)
    “…The aim of this study was to assess the microbiological and physicochemical stability of opioid solutions containing fentanyl or sufentanil and thereby…”
    Get full text
    Journal Article
  4. 4

    Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy by Borget, Isabelle, Laville, Isabelle, Paci, Angelo, Michiels, Stefan, Mercier, Lionel, Desmaris, Romain-Pacôme, Bourget, Philippe

    “…About 26,000 chemotherapeutic batches were produced in 2003 in the Institute Gustave Roussy and 83% were qualitatively and quantitatively assessed in…”
    Get full text
    Journal Article
  5. 5

    Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products by Bouligand, Jérôme, Storme, Thomas, Laville, Isabelle, Mercier, Lionel, Oberlin, Odile, Vassal, Gilles, Bourget, Philippe, Paci, Angelo

    “…Cyclophosphamide is an alkylating agent widely used from cancer chemotherapy to immunotherapy purposes. In paediatrics oncology, oral cyclophosphamide…”
    Get full text
    Journal Article
  6. 6

    5-aminolevulinic acid ester-induced protoporphyrin IX in a murine melanoma cell line by Vena, Flavia C B, Turchiello, Rozane F, Laville, Isabelle, Pigaglio, Sophie, Blais, Jocelyne, Tedesco, Antonio C

    Published in Lasers in medical science (01-10-2004)
    “…The use of 5-aminolevulinic acid (5-ALA) ester derivatives as precursors of endogenous protoporphyrin IX (PpIX) has been proposed as a good strategy for…”
    Get full text
    Journal Article